Authors will have the option to choose how their article is published.

Traditional publishing model: published articles are made available to institutions and individuals who subscribe to this journal or who pay to read specific articles. There is no charge to publish.

Open Access (OA) model: published articles are freely and permanently available online. Anyone, anywhere can read and build upon this research. If you would be interested in publishing Open Access in this journal please follow the link.

USAGE

• 17521Downloads 2024
  Springer measures the usage on the SpringerLink platform according to the COUNTER (Counting Online Usage of NeTworked Electronic Resources) standards.
• 56 Usage Factor 2023/2024
  The Springer Journal Usage Factor 2023/2024 was calculated as suggested by the COUNTER Code of Practice for Usage Factors. It is the median value of the number of downloads in 2023/2024 for all articles published online in that particular journal during the same time period. The Usage Factor calculation is based on COUNTER-compliant usage data on the SpringerLink platform. (Counting Online Usage of NeTworked Electronic Resources) standards.

WEB OF SCIENCE

• 0.4 Impact Factor 2024
  The journal Impact Factor is the average number of times articles from the journal published in the past two years have been cited in the JCR year. It is calculated by dividing the number of citations in the JCR year by the total number of articles published in the two previous years.
• 0.5 5 year Impact Factor 2024
  The 5-year journal Impact Factor is the average number of times articles from the journal published in the past five years have been cited in the JCR year. It is calculated by dividing the number of citations in the JCR year by the total number of articles published in the five previous years.
• Q4Quartile: Biochemistry & Molecular Biology 2024
  Quartiles indicate where a journal’s ranking lies within a particular subject category. These quartiles rank the journals from highest to lowest based on their impact factor. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
• 0.11 Journal Citation Indicator (Biochemistry & Molecular Biology) 2024
  The Journal Citation Indicator is a measure of the average Category Normalized Citation Impact (CNCI) of citable items (articles & reviews) published by a journal over a recent three year period. It is used to help you evaluate journals based on other metrics besides the Journal Impact Factor (JIF).

SCOPUS

• 1.0 CiteScore 2024
  CiteScore acts as an indicator of the citation level of peer-reviewed materials, which is calculated as the ratio of the average number of citations to the number of published documents. Therewith, the publication window is equal to four years.
• 0.18Source Normalized Impact per Paper (SNIP) 2024
  Source Normalized Impact per Paper (SNIP) measures contextual citation impact by weighting citations based on the total number of citations in a subject field. The impact of a single citation is given higher value in subject areas where citations are less likely, and vice versa.
• 0.206 SCImago Journal Rank (SJR) 2024
  SCImago Journal Rank (SJR) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.
• Q4Quartile: Molecular Medicine 2024
  Quartiles indicate where a journal’s ranking lies within a particular subject category. These quartiles rank the journals from highest to lowest based on their SJR. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
• 17H-Index 2024
  A journal has an H index of h if it published h papers each of which has been cited in other journals at least h times. Calculations are based on Scopus.

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry  covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.

Baidu, CLOCKSS, CNKI, CNPIEC, Dimensions, EBSCO, EMBASE, EMBiology, Emerging Sources Citation Index, Google Scholar, Japanese Science and Technology Agency (JST), Naver, OCLC WorldCat Discovery Service, Portico, ProQuest, Reaxys, SCImago, SCOPUS, Semantic Scholar, TD Net Discovery Service, WTI AG, Wanfang

Queries about submission issues, peer review process, or the status of your manuscript should be sent to the Editorial Office of Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry: biochmsb@pleiadesonline.com